GPT and Ascites: Among nonhematologic toxicities, the most frequently reported were AST changes in 32 patients (68.1%), increases in bilirubin in 18 (38.3%), ALT changes in 17 (36.2%), renal function impairment in 13 (27.7%), and ascites in 11 (23.4%).